Company profile
Arovella Therapeutics ASX: ALA
Focused on developing a unique iNKT cell therapy platform to treat cancer.
- Industry
- Biotechnology Research
- Employees
- 25
- Headquarters
- Melbourne, Victoria
- LinkedIn followers
- 4,291
- Office locations
- 1
Arovella Therapeutics ASX: ALA company summary
Arovella Therapeutics ASX: ALA is a company in the Biotechnology Research industry, headquartered in Melbourne, Victoria. On LinkedIn the company has around 25 employees and 4,291 followers. Its listed specialties include Biotechnology, Advanced Cell Therapy, Oncology, iNKT Cell Therapy, Invariant natural killer T (iNKT) cell therapy platform.
What technology does Arovella Therapeutics ASX: ALA use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Arovella Therapeutics ASX: ALA
Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.
Specialties
Where is Arovella Therapeutics ASX: ALA located?
Arovella Therapeutics ASX: ALA lists 1 location.
Compare companies similar to Arovella Therapeutics ASX: ALA
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Arovella Therapeutics ASX: ALA arovella.com | Biotechnology Research | 25 | - | Melbourne, Victoria |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Arovella Therapeutics ASX: ALA
What does Arovella Therapeutics ASX: ALA do?
Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.
How many employees does Arovella Therapeutics ASX: ALA have?
Arovella Therapeutics ASX: ALA has around 25 employees on LinkedIn.
Where is Arovella Therapeutics ASX: ALA headquartered?
Arovella Therapeutics ASX: ALA is headquartered in Melbourne, Victoria.
Build a lead list from companies like Arovella Therapeutics ASX: ALA
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.